> The <55 mg/dL group had a 33% lower rate of cardiovascular events. That’s surprising large, particularly for a 43-year study.

A 43-year study?! That would put the enrolment date starting in 1983, four years before the first clinically available statin.

The referenced study looked at cardiovascular endpoints at 3 years, not 43 years.